• Strategic expansion into the U.S. market with premium product offerings
• Growing industry recognition and partnerships
• Sale of Althea Pharmaceutical Cannabis Subsidiary
• Capital management and governance changes including CFO appointment and CEO resignation

Althea Group Holdings Ltd (ASX: AGH) released its June 2025 quarterly activities and cashflow report, detailing its strategic progress and financial performance. The company has expanded into the U.S. market through its Peak Processing Solutions business, developing premium, compliant products that have gained growing industry recognition and partnerships. Althea also announced the sale of its Althea Pharmaceutical Cannabis Subsidiary, as part of a broader capital management and governance strategy that included the appointment of a new CFO and the resignation of the CEO. The quarterly results showed some one-off outflows related to the subsidiary sale and legacy costs, but the company expects to see improved operating cash flows going forward as cost-saving measures take effect and revenues increase, particularly from the Peak Canada and Peak USA operations.

The company expects to see improved operating cash flows and revenue growth, particularly from its Peak Canada and Peak USA operations, as cost-saving measures take effect.

Althea Group Holdings is positioned for margin expansion and stronger financial performance in the next quarter and beyond, based on initiatives to improve operational cash flows, the execution of strategic actions that will bring annual savings, and revenue growth from Peak Canada and Peak USA.